Iradimed (NASDAQ:IRMD) Stock Rating Upgraded by StockNews.com
Iradimed (NASDAQ:IRMD – Get Free Report) was upgraded by stock analysts at StockNews.com from a “buy” rating to a “strong-buy” rating in a research note issued on Tuesday. Separately, Roth Mkm reiterated a “buy” rating and issued a $72.00 target price (up previously from $60.00) on shares of Iradimed in a research note on Friday, […]
Iradimed (NASDAQ:IRMD – Get Free Report) was upgraded by stock analysts at StockNews.com from a “buy” rating to a “strong-buy” rating in a research note issued on Tuesday. Separately, Roth Mkm reiterated a “buy” rating and issued a $72.00 target price (up previously from $60.00) on shares of Iradimed in a research note on Friday, […]
